English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
  Glycation and acetylation sites on fibrinogen in plasma fibrin clot of patients with type 2 diabetes: Effects of low-dose acetylsalicylic acid

Bryk, A. H., Zettl, K., Wisniewski, J. R., & Undas, A. (2021). Glycation and acetylation sites on fibrinogen in plasma fibrin clot of patients with type 2 diabetes: Effects of low-dose acetylsalicylic acid. Thrombosis Research, 198, 93-98. doi:10.1016/j.thromres.2020.11.031.

Item is

Basic

show hide
Genre: Journal Article

Files

show Files

Locators

show

Creators

show
hide
 Creators:
Bryk, Agata Hanna1, Author
Zettl, Katharina2, Author              
Wisniewski, Jacek R.2, Author              
Undas, Anetta1, Author
Affiliations:
1external, ou_persistent22              
2Mann, Matthias / Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Max Planck Society, ou_1565159              

Content

show
hide
Free keywords: Hematology; Cardiovascular System & Cardiology; Acetylsalicylic acid; Type 2 diabetes mellitus; Fibrinogen; Acetylation; Glycation;
 Abstract: Acetylsalicylic acid (ASA) and type 2 diabetes mellitus (T2DM) affect fibrin clot properties through fibrinogen acetylation or glycation. We aimed to identify glycation and acetylation sites on fibrinogen in plasma fibrin clot of T2DM patients with respect to effects of ASA and fibrin clot properties. In fibrin clots generated from plasma of 9 T2DM patients, we performed mass-spectrometric analysis of N epsilon-fructosyl-(FL), N epsilon-carboxyethyl-(CEL) and N epsilon carboxymethyl-lysine (CML), and acetylation sites, before and after one-month administration of 75 mg/d ASA confirmed with determination of thromboxane B2 concentration (TXB2), along with clot permeability and lysis time, and thrombin generation. In the proteomic analysis, 216 proteins were identified. Among 10 glycation sites identified in alpha, 10 in beta and 6 in gamma fibrinogen chain, there were 17 FL, 5 CEL and 4 CML sites. Some of glycation sites in fibrinogen were previously reported to be involved in cross-linking by factor XIII (alpha K-208, alpha K-448 and alpha K-539) and plasmin cleavage (alpha K-81). There were 7 acetylation sites in alpha and beta chains, and none in fibrinogen gamma chain. Two acetylation sites were identical with FL sites (alpha K-195 and beta-247), while one with CML site (beta K-353). In 7 patients with low post-ASA TXB2, intensity of acetylation, as well as clot properties were unaffected by ASA. This study identifies glycation and acetylation sites on fibrinogen in plasma fibrin clot of T2DM and supports the view that low-dose ASA does not increase fibrinogen acetylation in T2DM. Our findings suggest that glycation may block sites previously identified to be acetylated in vitro.

Details

show
hide
Language(s): eng - English
 Dates: 2021
 Publication Status: Published in print
 Pages: 6
 Publishing info: -
 Table of Contents: -
 Rev. Type: Peer
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: Thrombosis Research
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: Elmsford, N.Y. : Pergamon
Pages: - Volume / Issue: 198 Sequence Number: - Start / End Page: 93 - 98 Identifier: ISSN: 0049-3848
CoNE: https://pure.mpg.de/cone/journals/resource/110978984076419